Trait centric view

1. Trait name:	Bovine respiratory disease susceptibility
   Ontology terms:	CMO:0001107

   329 genes are associated with this trait, with QTL/association found

   • A2M: Alpha-2-macroglobulin
     evidenced by: QTL:160080; QTL:160081;
   • ABHD6: Abhydrolase domain containing 6, acylglycerol lipase
     evidenced by: QTL:160326;
   • ACACA: Acetyl-CoA carboxylase alpha
     evidenced by: QTL:160269;
   • ACADS: Acyl-CoA dehydrogenase short chain
     evidenced by: QTL:160256;
   • ACADSB: Acyl-CoA dehydrogenase short/branched chain
     evidenced by: QTL:160374;
   • ACADVL: Acyl-CoA dehydrogenase very long chain
     evidenced by: QTL:160277;
   • ACSM1: Acyl-CoA synthetase medium chain family member 1
     evidenced by: QTL:160354;
   • ADAM10: ADAM metallopeptidase domain 10
     evidenced by: QTL:160139;
   • ADAM9: ADAM metallopeptidase domain 9
     evidenced by: QTL:160376;
   • ADCYAP1: Adenylate cyclase activating polypeptide 1
     evidenced by: QTL:160348;
   • ADIPOQ: Adiponectin, C1Q and collagen domain containing
     evidenced by: QTL:159991;
   • ADORA3: Adenosine A3 receptor
     evidenced by: QTL:160037;
   • ADPGK: ADP dependent glucokinase
     evidenced by: QTL:160135;
   • AGO1: Argonaute RISC component 1
     evidenced by: QTL:160047;
   • AGO2: Argonaute 2, RISC catalytic component
     evidenced by: QTL:160183;
   • AHSG: Alpha 2-HS glycoprotein
     evidenced by: QTL:159995;
   • AKT1: AKT serine/threonine kinase 1
     evidenced by: QTL:160320; QTL:160321;
   • ALDH8A1: Aldehyde dehydrogenase 8 family member A1
     evidenced by: QTL:160073;
   • ALDOB: Aldolase, fructose-bisphosphate B
     evidenced by: QTL:160128;
   • ALOX5AP: Arachidonate 5-lipoxygenase activating protein
     evidenced by: QTL:160160;
   • AMDHD1: Amidohydrolase domain containing 1
     evidenced by: QTL:160069;
   • ANAPC10: Anaphase promoting complex subunit 10
     evidenced by: QTL:160244; QTL:160245;
   • ANAPC15: Anaphase promoting complex subunit 15
     evidenced by: QTL:160199;
   • ANKRA2: Ankyrin repeat, family A (RFXANK-like), 2
     evidenced by: QTL:19829; QTL:19830; QTL:19831; QTL:19832; QTL:19833; QTL:19834; QTL:19835;
   • ANXA10: Annexin A10
     evidenced by: QTL:137211;
   • APBA1: Amyloid beta (A4) precursor protein-binding, family A, member 1
     evidenced by: QTL:160123;
   • APBA2: Amyloid beta precursor protein binding family A member 2
     evidenced by: QTL:160308;
   • APOA1: Apolipoprotein A1
     evidenced by: QTL:160191;
   • APOC2: Apolipoprotein C2
     evidenced by: QTL:160268;
   • APOD: Apolipoprotein D
     evidenced by: QTL:159990;
   • APOE: Apolipoprotein E
     evidenced by: QTL:160267;
   • APP: Amyloid beta precursor protein
     evidenced by: QTL:159985;
   • AQP4: Aquaporin 4
     evidenced by: QTL:160346;
   • ARRB1: Arrestin beta 1
     evidenced by: QTL:160201; QTL:160202;
   • ASPH: Aspartate beta-hydroxylase
     evidenced by: QTL:160185; QTL:160186;
   • ATP1A2: ATPase Na+/K+ transporting subunit alpha 2
     evidenced by: QTL:160031;
   • ATP1B3: ATPase Na+/K+ transporting subunit beta 3
     evidenced by: QTL:160001;
   • BACE1: Beta-secretase 1
     evidenced by: QTL:160192; QTL:160193;
   • BAG5: BAG cochaperone 5
     evidenced by: QTL:160317; QTL:160318;
   • BHMT: Betaine--homocysteine S-methyltransferase
     evidenced by: QTL:160133;
   • BIRC5: Baculoviral IAP repeat containing 5
     evidenced by: QTL:160287; QTL:160288;
   • BMP4: Bone morphogenetic protein 4
     evidenced by: QTL:160141;
   • C3: Complement C3
     evidenced by: QTL:160107;
   • C6: Complement C6
     evidenced by: QTL:160298;
   • CACNA1C: Calcium voltage-gated channel subunit alpha1 C
     evidenced by: QTL:160085;
   • CACNA1D: Calcium channel, voltage-dependent, L type, alpha 1D subunit
     evidenced by: QTL:160327;
   • CACNB2: Calcium voltage-gated channel auxiliary subunit beta 2
     evidenced by: QTL:160168;
   • CACNG3: Calcium voltage-gated channel auxiliary subunit gamma 3
     evidenced by: QTL:160357;
   • CALB1: Calbindin 1
     evidenced by: QTL:160187;
   • CAMK2N2: Calcium/calmodulin dependent protein kinase II inhibitor 2
     evidenced by: QTL:159996;
   • CAPN3: Calpain 3, (p94)
     evidenced by: QTL:160136; QTL:160137;
   • CAPRIN1: Cell cycle associated protein 1
     evidenced by: QTL:160398;
   • CAST: Calpastatin
     evidenced by: QTL:160116; QTL:160117;
   • CAV1: Caveolin 1
     evidenced by: QTL:160052;
   • CBR4: Carbonyl reductase 4
     evidenced by: QTL:160118;
   • CD180: CD180 molecule
     evidenced by: QTL:19836; QTL:19837;
   • CDC23: Cell division cycle 23
     evidenced by: QTL:160112;
   • CDC26: Cell division cycle 26
     evidenced by: QTL:160130;
   • CDKN2D: Cyclin dependent kinase inhibitor 2D
     evidenced by: QTL:160106;
   • CHORDC1: Cysteine and histidine rich domain containing 1
     evidenced by: QTL:160386;
   • CHRM2: Cholinergic receptor muscarinic 2
     evidenced by: QTL:160054; QTL:160055;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:160379; QTL:160380;
   • CHRNA7: Cholinergic receptor, nicotinic, alpha 7
     evidenced by: QTL:160309; QTL:160310;
   • CLU: Clusterin
     evidenced by: QTL:160121;
   • COA8: Cytochrome c oxidase assembly factor 8
     evidenced by: QTL:160315; QTL:160316;
   • COP1: COP1 E3 ubiquitin ligase
     evidenced by: QTL:160217;
   • CPT1B: Carnitine palmitoyltransferase 1B
     evidenced by: QTL:160088;
   • CPT2: Carnitine palmitoyltransferase 2
     evidenced by: QTL:160043;
   • CREB3L2: CAMP responsive element binding protein 3 like 2
     evidenced by: QTL:137204;
   • CROT: Carnitine O-octanoyltransferase
     evidenced by: QTL:160050;
   • CRYAB: Crystallin alpha B
     evidenced by: QTL:160189;
   • CYCT: Cytochrome c, testis
     evidenced by: QTL:160009;
   • DAP: Death associated protein
     evidenced by: QTL:160302; QTL:160303;
   • DDIT4: DNA damage inducible transcript 4
     evidenced by: QTL:160383;
   • DEGS1: Delta 4-desaturase, sphingolipid 1
     evidenced by: QTL:160211;
   • DGCR8: DGCR8 microprocessor complex subunit
     evidenced by: QTL:160262;
   • DICER1: Dicer 1, ribonuclease III
     evidenced by: QTL:160314;
   • DNAJA1: DnaJ heat shock protein family (Hsp40) member A1
     evidenced by: QTL:160126;
   • DNMT1: DNA (cytosine-5-)-methyltransferase 1
     evidenced by: QTL:160105;
   • DPP6: Dipeptidyl-peptidase 6
     evidenced by: QTL:160060;
   • DPYD: Dihydropyrimidine dehydrogenase
     evidenced by: QTL:160038;
   • DRD2: Dopamine receptor D2
     evidenced by: QTL:160190;
   • DROSHA: Drosha ribonuclease III
     evidenced by: QTL:160301;
   • DSE: Dermatan sulfate epimerase
     evidenced by: QTL:160071;
   • DUSP14: Dual specificity phosphatase 14
     evidenced by: QTL:160270;
   • DUSP18: Dual specificity phosphatase 18
     evidenced by: QTL:160259;
   • ECE2: Endothelin converting enzyme 2
     evidenced by: QTL:159997;
   • EDN2: Endothelin 2
     evidenced by: QTL:160045;
   • EDNRB: Endothelin receptor type B
     evidenced by: QTL:160161;
   • EIF4A3: Eukaryotic translation initiation factor 4A3
     evidenced by: QTL:160285;
   • EIF4EBP1: Eukaryotic translation initiation factor 4E binding protein 1
     evidenced by: QTL:160375;
   • ELOVL5: ELOVL fatty acid elongase 5
     evidenced by: QTL:160342;
   • ELOVL7: ELOVL fatty acid elongase 7
     evidenced by: QTL:160297;
   • ENOPH1: Enolase-phosphatase 1
     evidenced by: QTL:160097;
   • ENTPD5: Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)
     evidenced by: QTL:160145;
   • ERO1A: Endoplasmic reticulum oxidoreductase 1 alpha
     evidenced by: QTL:160134;
   • ESR1: Estrogen receptor 1
     evidenced by: QTL:160075;
   • FADD: Fas associated via death domain
     evidenced by: QTL:160392; QTL:160393;
   • FADS2: Fatty acid desaturase 2
     evidenced by: QTL:160387;
   • FADS3: Fatty acid desaturase 3
     evidenced by: QTL:160388;
   • FADS6: Fatty acid desaturase 6
     evidenced by: QTL:160290;
   • FAM162A: Family with sequence similarity 162 member A
     evidenced by: QTL:159986; QTL:159987;
   • FASN: Fatty acid synthase
     evidenced by: QTL:160281;
   • FBP1: Fructose-bisphosphatase 1
     evidenced by: QTL:160127;
   • FETUB: Fetuin B
     evidenced by: QTL:159993; QTL:159994;
   • FGL2: Fibrinogen like 2
     evidenced by: QTL:160051;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:160324; QTL:160325;
   • FN1: Fibronectin 1
     evidenced by: QTL:160015;
   • FURIN: Furin, paired basic amino acid cleaving enzyme
     evidenced by: QTL:160307;
   • GABRB1: Gamma-aminobutyric acid type A receptor subunit beta1
     evidenced by: QTL:160094;
   • GABRG2: Gamma-aminobutyric acid type A receptor subunit gamma2
     evidenced by: QTL:160114;
   • GATM: Glycine amidinotransferase
     evidenced by: QTL:160140;
   • GC: Group-specific component (vitamin D binding protein)
     evidenced by: QTL:160095;
   • GLRA1: Glycine receptor alpha 1
     evidenced by: QTL:160113;
   • GLUL: Glutamate-ammonia ligase
     evidenced by: QTL:160218;
   • GPI: Glucose-6-phosphate isomerase
     evidenced by: QTL:160264;
   • GPLD1: Glycosylphosphatidylinositol specific phospholipase D1
     evidenced by: QTL:160344;
   • GPR158: G protein-coupled receptor 158
     evidenced by: QTL:160166;
   • GRK3: G protein-coupled receptor kinase 3
     evidenced by: QTL:160257;
   • GRK5: G protein-coupled receptor kinase 5
     evidenced by: QTL:160373;
   • GRK7: G protein-coupled receptor kinase 7
     evidenced by: QTL:160002;
   • GUCY1A1: Guanylate cyclase 1 soluble subunit alpha 1
     evidenced by: QTL:160247;
   • GUCY1A2: Guanylate cyclase 1 soluble subunit alpha 2
     evidenced by: QTL:160188;
   • GUCY1B1: Guanylate cyclase 1 soluble subunit beta 1
     evidenced by: QTL:160248;
   • GULO: Gulonolactone (L-) oxidase
     evidenced by: QTL:160125;
   • HAAO: 3-hydroxyanthranilate 3,4-dioxygenase
     evidenced by: QTL:160147;
   • HACD2: 3-hydroxyacyl-CoA dehydratase 2
     evidenced by: QTL:159988;
   • HACD4: 3-hydroxyacyl-CoA dehydratase 4
     evidenced by: QTL:160122;
   • HAL: Histidine ammonia-lyase
     evidenced by: QTL:160070;
   • HK1: Hexokinase 1
     evidenced by: QTL:160382;
   • HOGA1: 4-hydroxy-2-oxoglutarate aldolase 1
     evidenced by: QTL:160369;
   • HPGD: 15-hydroxyprostaglandin dehydrogenase
     evidenced by: QTL:160120;
   • HSD17B12: Hydroxysteroid (17-beta) dehydrogenase 12
     evidenced by: QTL:160208;
   • HTR2A: 5-hydroxytryptamine receptor 2A
     evidenced by: QTL:160158; QTL:160159;
   • HYAL2: Hyaluronidase 2
     evidenced by: QTL:160330;
   • ICOS: Inducible T cell costimulator
     evidenced by: QTL:160014;
   • IFI6: Interferon alpha inducible protein 6
     evidenced by: QTL:160022;
   • IFT57: Intraflagellar transport 57
     evidenced by: QTL:160397;
   • IGF1R: Insulin-like growth factor 1 receptor
     evidenced by: QTL:160305;
   • IL12RB2: Interleukin 12 receptor, beta 2
     evidenced by: QTL:160041;
   • IL1B: Interleukin 1 beta
     evidenced by: QTL:160153; QTL:160154;
   • IL6: Interleukin 6
     evidenced by: QTL:160049;
   • IMPACT: Impact RWD domain protein
     evidenced by: QTL:160347;
   • INSIG1: Insulin induced gene 1
     evidenced by: QTL:160061;
   • IRAG1: Inositol 1,4,5-triphosphate receptor associated 1
     evidenced by: QTL:160197;
   • IRAK2: Interleukin 1 receptor associated kinase 2
     evidenced by: QTL:160323;
   • ITGA3: Integrin subunit alpha 3
     evidenced by: QTL:160280;
   • ITGAL: Integrin subunit alpha L
     evidenced by: QTL:160362;
   • ITGAV: Integrin subunit alpha V
     evidenced by: QTL:160007;
   • ITGB5: Integrin subunit beta 5
     evidenced by: QTL:159989;
   • ITIH1: Inter-alpha-trypsin inhibitor heavy chain 1
     evidenced by: QTL:160328; QTL:160329;
   • ITIH5: Inter-alpha-trypsin inhibitor heavy chain 5
     evidenced by: QTL:160163; QTL:160164;
   • ITPR3: Inositol 1,4,5-trisphosphate receptor type 3
     evidenced by: QTL:137220;
   • KCNH1: Potassium voltage-gated channel subfamily H member 1
     evidenced by: QTL:160221;
   • KCNIP3: Potassium voltage-gated channel interacting protein 3
     evidenced by: QTL:160146;
   • KCNJ2: Potassium inwardly rectifying channel subfamily J member 2
     evidenced by: QTL:160291;
   • KCNJ3: Potassium inwardly rectifying channel subfamily J member 3
     evidenced by: QTL:160011;
   • KCNMA1: Potassium calcium-activated channel subfamily M alpha 1
     evidenced by: QTL:160384;
   • KCNMB1: Potassium calcium-activated channel subfamily M regulatory beta subunit 1
     evidenced by: QTL:160294;
   • KCNMB4: Potassium calcium-activated channel subfamily M regulatory beta subunit 4
     evidenced by: QTL:160067;
   • KCNQ3: Potassium voltage-gated channel subfamily Q member 3
     evidenced by: QTL:160184;
   • KDR: Kinase insert domain receptor
     evidenced by: QTL:137210;
   • KNG1: Kininogen 1
     evidenced by: QTL:159992;
   • LAPTM5: Lysosomal protein transmembrane 5
     evidenced by: QTL:160020;
   • LCMT1: Leucine carboxyl methyltransferase 1
     evidenced by: QTL:160359; QTL:160360;
   • LEP: Leptin
     evidenced by: QTL:160053;
   • LGR4: Leucine rich repeat containing G protein-coupled receptor 4
     evidenced by: QTL:160205;
   • LONP2: Lon peptidase 2, peroxisomal
     evidenced by: QTL:160263;
   • LPL: Lipoprotein lipase
     evidenced by: QTL:160124;
   • LTA4H: Leukotriene A4 hydrolase
     evidenced by: QTL:160077;
   • LTC4S: Leukotriene C4 synthase
     evidenced by: QTL:160100;
   • MAPK10: Mitogen-activated protein kinase 10
     evidenced by: QTL:160099;
   • MAPK13: Mitogen-activated protein kinase 13
     evidenced by: QTL:160339;
   • MAPK14: Mitogen-activated protein kinase 14
     evidenced by: QTL:160338;
   • MAPK3: Mitogen-activated protein kinase 3
     evidenced by: QTL:160361;
   • MAPK8: Mitogen-activated protein kinase 8
     evidenced by: QTL:160385;
   • MAPKAP1: Mitogen-activated protein kinase associated protein 1
     evidenced by: QTL:137214;
   • MECR: Mitochondrial trans-2-enoyl-CoA reductase
     evidenced by: QTL:160021;
   • MEN1: Menin 1
     evidenced by: QTL:160390; QTL:160391;
   • MGST2: Microsomal glutathione S-transferase 2
     evidenced by: QTL:160246;
   • MIF: Macrophage migration inhibitory factor
     evidenced by: QTL:160260; QTL:160261;
   • MIP: Major intrinsic protein of lens fiber
     evidenced by: QTL:160068;
   • MPZ: Myelin protein zero
     evidenced by: QTL:160030;
   • MPZL1: Myelin protein zero like 1
     evidenced by: QTL:160027;
   • MTHFD1L: Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like
     evidenced by: QTL:160074;
   • MTR: 5-methyltetrahydrofolate-homocysteine methyltransferase
     evidenced by: QTL:160378;
   • NCALD: Neurocalcin delta
     evidenced by: QTL:137215;
   • NDUFAB1: NADH:ubiquinone oxidoreductase subunit AB1
     evidenced by: QTL:160355;
   • NLRP3: NLR family pyrin domain containing 3
     evidenced by: QTL:160110;
   • NOS1: Nitric oxide synthase 1
     evidenced by: QTL:160253;
   • NOS2: Nitric oxide synthase 2
     evidenced by: QTL:160272;
   • NR1H3: Nuclear receptor subfamily 1 group H member 3
     evidenced by: QTL:160209; QTL:160210;
   • NR2F2: Nuclear receptor subfamily 2 group F member 2
     evidenced by: QTL:160306;
   • NUB1: Negative regulator of ubiquitin like proteins 1
     evidenced by: QTL:160058; QTL:160059;
   • NXN: Nucleoredoxin
     evidenced by: QTL:160274;
   • P2RX4: Purinergic receptor P2X 4
     evidenced by: QTL:160250;
   • PAX6: Paired box 6
     evidenced by: QTL:160206;
   • PBLD: Phenazine biosynthesis like protein domain containing
     evidenced by: QTL:160381;
   • PDE10A: Phosphodiesterase 10A
     evidenced by: QTL:160076;
   • PDE11A: Phosphodiesterase 11A
     evidenced by: QTL:160010;
   • PDE1A: Phosphodiesterase 1A
     evidenced by: QTL:160008;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:160063;
   • PDE2A: Phosphodiesterase 2A
     evidenced by: QTL:160200;
   • PDE3A: Phosphodiesterase 3A, cGMP-inhibited
     evidenced by: QTL:160079;
   • PDE6G: Phosphodiesterase 6G
     evidenced by: QTL:160283; QTL:160284;
   • PDE9A: Phosphodiesterase 9A
     evidenced by: QTL:160003;
   • PEBP1: Phosphatidylethanolamine binding protein 1
     evidenced by: QTL:160251; QTL:160252;
   • PFKM: Phosphofructokinase, muscle
     evidenced by: QTL:160065;
   • PGK1: Phosphoglycerate kinase 1
     evidenced by: QTL:160394;
   • PKIG: CAMP-dependent protein kinase inhibitor gamma
     evidenced by: QTL:160179;
   • PLA2G4A: Phospholipase A2 group IVA
     evidenced by: QTL:160220;
   • PLAT: Plasminogen activator, tissue type
     evidenced by: QTL:160377;
   • PLAUR: Plasminogen activator, urokinase receptor
     evidenced by: QTL:160266;
   • PLCB1: Phospholipase C beta 1
     evidenced by: QTL:160162;
   • PLK1: Polo like kinase 1
     evidenced by: QTL:160356;
   • PLPP3: Phospholipid phosphatase 3
     evidenced by: QTL:160042;
   • POLR2E: RNA polymerase II, I and III subunit E
     evidenced by: QTL:160111;
   • POLR2I: RNA polymerase II subunit I
     evidenced by: QTL:160265;
   • PPARG: Peroxisome proliferator-activated receptor gamma
     evidenced by: QTL:160336;
   • PPARGC1A: Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
     evidenced by: QTL:160092;
   • PRDX3: Peroxiredoxin 3
     evidenced by: QTL:160371; QTL:160372;
   • PRKACA: Protein kinase cAMP-activated catalytic subunit alpha
     evidenced by: QTL:160102;
   • PRKAG1: Protein kinase AMP-activated non-catalytic subunit gamma 1
     evidenced by: QTL:160064;
   • PRKAG3: Protein kinase, AMP-activated, gamma 3 non-catalytic subunit
     evidenced by: QTL:160018;
   • PRKAR2A: Protein kinase cAMP-dependent type II regulatory subunit alpha
     evidenced by: QTL:160333;
   • PRKCA: Protein kinase C alpha
     evidenced by: QTL:160293;
   • PRKCE: Protein kinase C, epsilon
     evidenced by: QTL:160148;
   • PRKCI: Protein kinase C iota
     evidenced by: QTL:160000;
   • PRKCQ: Protein kinase C theta
     evidenced by: QTL:160165;
   • PRKG1: Protein kinase, cGMP-dependent, type I
     evidenced by: QTL:160368;
   • PRKG2: Protein kinase cGMP-dependent 2
     evidenced by: QTL:160096;
   • PRKRIP1: PRKR interacting protein 1
     evidenced by: QTL:160365;
   • PRL: Prolactin
     evidenced by: QTL:160345;
   • PRNP: Prion protein
     evidenced by: QTL:160172;
   • PRR5L: Proline rich 5 like
     evidenced by: QTL:160207;
   • PSEN1: Presenilin 1
     evidenced by: QTL:160142; QTL:160143;
   • PSEN2: Presenilin 2
     evidenced by: QTL:160212; QTL:160213;
   • PSME4: Proteasome activator subunit 4
     evidenced by: QTL:160150; QTL:160152;
   • PSMF1: Proteasome inhibitor subunit 1
     evidenced by: QTL:160174; QTL:160175;
   • PSMG2: Proteasome assembly chaperone 2
     evidenced by: QTL:160349; QTL:160350;
   • PSPH: Phosphoserine phosphatase
     evidenced by: QTL:160363;
   • PTGIS: Prostaglandin I2 synthase
     evidenced by: QTL:160182;
   • PTGS2: Prostaglandin-endoperoxide synthase 2
     evidenced by: QTL:160219;
   • PTI: Pancreatic trypsin inhibitor
     evidenced by: QTL:160181;
   • PTPA: Protein phosphatase 2 phosphatase activator
     evidenced by: QTL:160155;
   • PYCR1: Pyrroline-5-carboxylate reductase 1
     evidenced by: QTL:160282;
   • PYGL: Glycogen phosphorylase L
     evidenced by: QTL:160138;
   • RAD23A: RAD23 homolog A, nucleotide excision repair protein
     evidenced by: QTL:160103; QTL:160104;
   • RAD23B: RAD23 homolog B, nucleotide excision repair protein
     evidenced by: QTL:160129;
   • RGS4: Regulator of G protein signaling 4
     evidenced by: QTL:160029;
   • RGS5: Regulator of G protein signaling 5
     evidenced by: QTL:160028;
   • RGS7: Regulator of G protein signaling 7
     evidenced by: QTL:160214;
   • RGS9: Regulator of G protein signaling 9
     evidenced by: QTL:160292;
   • RHBG: Rh family B glycoprotein
     evidenced by: QTL:160032;
   • RHO: Rhodopsin
     evidenced by: QTL:160335;
   • S100A8: S100 calcium binding protein A8
     evidenced by: QTL:160033; QTL:160034;
   • S100A9: S100 calcium binding protein A9
     evidenced by: QTL:160035; QTL:160036;
   • SACM1L: SAC1 like phosphatidylinositide phosphatase
     evidenced by: QTL:160334;
   • SCARB1: Scavenger receptor class B member 1
     evidenced by: QTL:160249;
   • SCD5: Stearoyl-CoA desaturase 5
     evidenced by: QTL:160098;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:160370;
   • SCN3B: Sodium voltage-gated channel beta subunit 3
     evidenced by: QTL:160196;
   • SCN4B: Sodium voltage-gated channel beta subunit 4
     evidenced by: QTL:160194;
   • SCNN1A: Sodium channel epithelial 1 subunit alpha
     evidenced by: QTL:160082;
   • SDS: Serine dehydratase
     evidenced by: QTL:160254;
   • SERPINA14: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 14
     evidenced by: QTL:160312;
   • SERPINA1: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
     evidenced by: QTL:160311;
   • SERPINA5: Serpin family A member 5
     evidenced by: QTL:160313;
   • SERPINB10: Serpin family B member 10
     evidenced by: QTL:160352;
   • SERPINC1: Serpin family C member 1
     evidenced by: QTL:160215; QTL:160216;
   • SERPINF1: Serpin family F member 1
     evidenced by: QTL:160275;
   • SERPINF2: Serpin family F member 2
     evidenced by: QTL:160276;
   • SERPING1: Serpin family G member 1
     evidenced by: QTL:160399;
   • SERPINH1: Serpin family H member 1
     evidenced by: QTL:160203; QTL:160204;
   • SFN: Stratifin
     evidenced by: QTL:160023; QTL:160024;
   • SH3RF1: SH3 domain containing ring finger 1
     evidenced by: QTL:160119;
   • SIRT4: Sirtuin 4
     evidenced by: QTL:160255;
   • SLC14A1: Solute carrier family 14 member 1
     evidenced by: QTL:160351;
   • SLC1A3: Solute carrier family 1 member 3
     evidenced by: QTL:160299;
   • SLC22A6: Solute carrier family 22 member 6
     evidenced by: QTL:160389;
   • SLC2A1: Solute carrier family 2 member 1
     evidenced by: QTL:160044;
   • SLC52A3: Solute carrier family 52 member 3
     evidenced by: QTL:160176;
   • SLC6A13: Solute carrier family 6 member 13
     evidenced by: QTL:160084;
   • SLC6A3: Solute carrier family 6 member 3
     evidenced by: QTL:160304;
   • SLC6A4: Solute carrier family 6 member 4
     evidenced by: QTL:160273;
   • SLC6A6: Solute carrier family 6 member 6
     evidenced by: QTL:160337;
   • SNCA: Synuclein alpha
     evidenced by: QTL:160089; QTL:160090; QTL:160091;
   • SNTA1: Syntrophin alpha 1
     evidenced by: QTL:160178;
   • SOCS2: Suppressor of cytokine signaling 2
     evidenced by: QTL:160062;
   • SOCS5: Suppressor of cytokine signaling 5
     evidenced by: QTL:160149;
   • SSPO: SCO-spondin
     evidenced by: QTL:160057;
   • SSTR5: Somatostatin receptor 5
     evidenced by: QTL:160353;
   • STIM1: Stromal interaction molecule 1
     evidenced by: QTL:160198;
   • STK38: Serine/threonine kinase 38
     evidenced by: QTL:160340;
   • SUMO1: Small ubiquitin like modifier 1
     evidenced by: QTL:160012; QTL:160013;
   • SYNDIG1: Synapse differentiation inducing 1
     evidenced by: QTL:160171;
   • TAF9: TATA-box binding protein associated factor 9
     evidenced by: QTL:160295; QTL:160296;
   • TBXAS1: Thromboxane A synthase 1
     evidenced by: QTL:160056;
   • TECR: Trans-2,3-enoyl-CoA reductase
     evidenced by: QTL:160101;
   • TIMP1: TIMP metallopeptidase inhibitor 1
     evidenced by: QTL:160395; QTL:160396;
   • TIMP2: TIMP metallopeptidase inhibitor 2
     evidenced by: QTL:160286;
   • TIMP3: TIMP metallopeptidase inhibitor 3
     evidenced by: QTL:160078;
   • TNF: Tumor necrosis factor
     evidenced by: QTL:160343;
   • TNFAIP8: TNF alpha induced protein 8
     evidenced by: QTL:160108; QTL:160109;
   • TNFRSF1A: TNF receptor superfamily member 1A
     evidenced by: QTL:160083;
   • TNRC6A: Trinucleotide repeat containing adaptor 6A
     evidenced by: QTL:160358;
   • TNRC6B: Trinucleotide repeat containing adaptor 6B
     evidenced by: QTL:160087;
   • TNRC6C: Trinucleotide repeat containing adaptor 6C
     evidenced by: QTL:160289;
   • TRIB3: Tribbles pseudokinase 3
     evidenced by: QTL:160177;
   • TRIM71: Tripartite motif containing 71
     evidenced by: QTL:160322;
   • TRIP12: Thyroid hormone receptor interactor 12
     evidenced by: QTL:160019;
   • TUBA1A: Tubulin, alpha 1a
     evidenced by: QTL:137209;
   • UBE2K: Ubiquitin conjugating enzyme E2 K
     evidenced by: QTL:160093;
   • UFL1: UFM1 specific ligase 1
     evidenced by: QTL:160072;
   • USP13: Ubiquitin specific peptidase 13
     evidenced by: QTL:159998; QTL:159999;
   • USP20: Ubiquitin specific peptidase 20
     evidenced by: QTL:160156; QTL:160157;
   • USP22: Ubiquitin specific peptidase 22
     evidenced by: QTL:160278; QTL:160279;
   • USP2: Ubiquitin specific peptidase 2
     evidenced by: QTL:160195;
   • USP33: Ubiquitin specific peptidase 33
     evidenced by: QTL:160039; QTL:160040;
   • USP37: Ubiquitin specific peptidase 37
     evidenced by: QTL:160016;
   • USP42: Ubiquitin specific peptidase 42
     evidenced by: QTL:160366;
   • USP4: Ubiquitin specific peptidase 4
     evidenced by: QTL:160331; QTL:160332;
   • VDR: Vitamin D receptor
     evidenced by: QTL:160066;
   • VIL1: Villin 1
     evidenced by: QTL:160017;
   • XBP1: X-box binding protein 1
     evidenced by: QTL:160258;
   • XPO5: Exportin 5
     evidenced by: QTL:160341;
   • YWHAB: Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
     evidenced by: QTL:160180;
   • ZGPAT: Zinc finger CCCH-type and G-patch domain containing
     evidenced by: QTL:160173;
   • ZNF12: Zinc finger protein 12
     evidenced by: QTL:160367;